Summit Therapeutics (SMMT) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.76
-0.52
-0.29
-0.05

Details

Expected EPS
-0.090813
Actual EPS
-0.76
Surprise EPS
-0.67
Surprise Percent
+736.88%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.76 per share for Q3 2025.

0 Comments

Share your thoughts